Institutional investors hold a majority ownership of MYGN through the 141.95% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $828.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LUXOR CAPITAL GROUP LP Bought 2.9 Million shares of Myriad Genetics Inc
FIR TREE, INC. Bought 2.2 Million shares of Myriad Genetics Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.9 Million shares of Myriad Genetics Inc